Alpelisib (Alpelisib) targeted drug side effects

Alpelisib (Alpelisib) is an inhibitor targeting PI3Kα and is used to treat hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer carrying PIK3CA gene mutations. Although Apelvis has shown significant efficacy in treating breast cancer, like many drugs, it can cause a range of side effects. Here is more information about the possible side effects of Apelix:

Common side effects:

1.Hyperglycemia: Hyperglycemia is one of the common side effects of Apelvis. This may require additional monitoring and adjustments in patients with diabetes. Patients may need to take additional medications to control high blood sugar levels.

2.Skin reactions: Including skin problems such as rash, itching, dryness and inflammation. These reactions may require special skin care and medication management.

3.Diarrhea: During treatment with Apelvis, patients may experience diarrhea. This may require dietary changes or medication to relieve symptoms.

4.Abnormal liver function: Some patients may develop abnormal liver function, manifested by elevated liver enzyme levels, while taking apelvis. Doctors usually monitor a patient's liver function and take action if necessary.

Serious but rare side effects:

1.Pneumonitis: There are reports that the use of Apelvis may cause pneumonia, a rare but serious side effect. Patients should closely monitor respiratory symptoms during treatment and seek prompt medical treatment if necessary.

2.Hyperinsulinemia: Some patients may experience increased insulin levels, which may lead to increased blood sugar. This may require additional management in patients with insulin resistance.

3.Electrocardiogram (ECG) changes: In some patients, apelvis may cause a prolongation of the QT interval, which is an indicator of the heart's electrical activity. Doctors usually perform EKG monitoring before and during treatment.

Management and Advice:

1.Regular monitoring: Doctors will recommend that patients conduct regular biological monitoring during the use of Apelvis, including examinations of blood sugar, liver function, electrocardiogram, etc., as well as monitoring of possible side effects.

2.Symptom management: For specific side effects, doctors may recommend that patients take some symptom management measures. For example, for skin reactions, specific skin care products can be used.

3.Dose adjustment: When necessary, doctors may consider adjusting the dose of Apelvis to reduce the occurrence of side effects or reduce the severity of symptoms.

4.Individualized treatment: Since each patient’s physiological condition and response are different, the treatment plan needs to be individualized. The doctor will develop the most appropriate treatment plan based on the patient's specific situation.

Notes:

1.Inform your doctor: Patients should inform their doctor about their medical history, drug allergies, and current medications before using Apelvis to ensure safe use.

2.Regular follow-up: During treatment with Apelvis, patients should receive regular follow-up visits from their doctor to report any new symptoms or changes.

3.Drug interactions: Patients should avoid possible interactions with certain medications while taking Apelvis. This needs to be managed under the guidance of a doctor.

Overall, Apelvis is a drug that has shown significant efficacy in selected breast cancer patients, but patients and physicians need to work closely to monitor and manage potential side effects to ensure patients receive maximum benefit and minimize potential risks. This also highlights the importance of individualized treatment and close monitoring when using any medication.

Apelis has not yet been launched in China, so it is not included in medical insurance. Therefore, patients cannot purchase it domestically and need to purchase Apelis through overseas channels. In foreign countries, the original Apelvis drug is mainly used. There are European and Indian versions of the original drug on the market. The price of the European version of the original drug is as high as tens of thousands of yuan. Relatively speaking, the price of the Indian version of the original drug is around four to five thousand yuan. The price is still relatively cheap. Moreover, the ingredients and efficacy of the European and Indian original drugs are consistent.